Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Lumbrokinase | Manufacture Date | Feb.21.2025 |
Batch Number | SW250221 | Analysis Date | Feb.22.2025 |
Batch Quantity | 50kg | Expiry Date | Feb.21.2027 |
Items | Specifications | Results |
Appearance | Light Brown powder | Complies |
Odor | Characteristic | Complies |
Taste | Characteristic | Complies |
Particle Size | 100% pass 80 mesh | Complies |
Loss on drying | < 5.0% | 2.25% |
Residue on ignition | < 0.1% | 0.05% |
Solubility | Soluble in water (25mg/ml) | Complies |
Residual Ethanol | < 0.5% | Complies |
Heavy metals | < 10PPM | Complies |
Na | < 0.1% | Complies |
Pb | <3.0PPM | Complies |
Total plate count | <1000CFU/G | Complies |
Yeast and mold | <100 CFU/G | Complies |
Salmonella | Negative | Complies |
E.Coli | Negative | Complies |
Plasmin activity | 10000FU/mg | Complies |
Packing description | Sealed export grade drum & double of sealed plastic bag |
Storage | Store in a cool and dry place, stay away from strong light and heat |
Shelf life | 2 years when properly stored |
Similiar product recommendation | |||
Capecitabine | Everolimus | Afatinib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Cediranib |
Cabozantinib | Selumetinib | Cetilistat | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Ponatinib |